Haiti
Tuberculosis profile
| High HIV burden |
Population  2012 10 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 2.6 (1–4.9) 25 (10–48)
Mortality (HIV+TB only) 1 (0.87–1.2) 10 (8.5–12)
Prevalence  (includes HIV+TB) 30 (14–52) 296 (140–509)
Incidence  (includes HIV+TB) 22 (18–26) 213 (176–254)
Incidence (HIV+TB only) 4.3 (3.5–5.1) 42 (35–50)
Case detection, all forms (%) 76 (64–93)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 9 254 (57) Relapse 444 (74)
Smear-negative 4 956 (31) Treatment after failure 78 (13)
Smear-unknown / not done 0 (0) Treatment after default 75 (13)
Extrapulmonary 1 914 (12) Other 2 (<1)
Other 0 (0)      
Total new 16 124   Total retreatment 599  
           
Other (history unknown)          
Total new and relapse 16 568   Total cases notified 16 723  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.0 1.1 1.1
Age < 15 286 1 339 379
Laboratories 2012
Smear (per 100 000 population) 2.5
Culture (per 5 million population) 1.0
Drug susceptibility testing (per 5 million population) 1.0
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 84   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 78  
Retreatment 72  
TB/HIV 2012 Number (%)
TB patients with known HIV status 13 518 (81)
HIV-positive TB patients 2 705 (20)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 604 (59)
HIV-positive TB patients on antiretroviral therapy (ART) 1 252 (46)
HIV-positive people screened for TB 2 105  
HIV-positive people provided with IPT 15 283  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.4–3.1) 14 (4.6–23)
MDR-TB cases among notified pulmonary
TB cases
310 (200–440) 82 (28–140)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB   81 (14%) 81
Laboratory-confirmed MDR-TB cases   81 81
Patients started on MDR-TB treatment     62
Financing TB control 2013
National TB programme budget (US$ millions) 12
% Funded domestically  
% Funded internationally 43%
% Unfunded 57%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data